Lars Fruergaard Jørgensen Joins the ZymoGenetics, Inc. Board of Directors

SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced that Lars Fruergaard Jørgensen of Novo Nordisk A/S was elected to the company’s Board of Directors at the annual meeting of shareholders. He replaces Lars Rebien Sørensen, a previous Novo Nordisk representative, who resigned from the Board in March 2010. Novo Nordisk holds approximately 27% of the company’s outstanding shares.

MORE ON THIS TOPIC